Rank | Gene Set | Z-score |
---|---|---|
1 | transcytosis (GO:0045056) | 8.31044476 |
2 | sterol catabolic process (GO:0016127) | 7.83836165 |
3 | cholesterol catabolic process (GO:0006707) | 7.83836165 |
4 | intestinal absorption (GO:0050892) | 7.74340526 |
5 | * cobalamin metabolic process (GO:0009235) | 7.62364470 |
6 | peptidyl-proline hydroxylation (GO:0019511) | 7.27292691 |
7 | negative regulation of digestive system process (GO:0060457) | 6.68143956 |
8 | glycolipid catabolic process (GO:0019377) | 6.59786390 |
9 | cysteine metabolic process (GO:0006534) | 6.46421137 |
10 | regulation of phospholipase A2 activity (GO:0032429) | 6.41697418 |
11 | membrane lipid catabolic process (GO:0046466) | 6.19123218 |
12 | proline biosynthetic process (GO:0006561) | 5.99778802 |
13 | COPI coating of Golgi vesicle (GO:0048205) | 5.82417927 |
14 | Golgi transport vesicle coating (GO:0048200) | 5.82417927 |
15 | protein hydroxylation (GO:0018126) | 5.62953021 |
16 | ceramide catabolic process (GO:0046514) | 5.57132669 |
17 | branched-chain amino acid catabolic process (GO:0009083) | 5.40079688 |
18 | valine metabolic process (GO:0006573) | 5.09882569 |
19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.03014127 |
20 | cellular modified amino acid catabolic process (GO:0042219) | 4.96047860 |
21 | mitochondrial calcium ion transport (GO:0006851) | 4.82991112 |
22 | positive regulation of nuclease activity (GO:0032075) | 4.82006096 |
23 | serine family amino acid biosynthetic process (GO:0009070) | 4.78865174 |
24 | protein maturation by protein folding (GO:0022417) | 4.76583491 |
25 | branched-chain amino acid metabolic process (GO:0009081) | 4.75383407 |
26 | positive regulation of pseudopodium assembly (GO:0031274) | 4.65855291 |
27 | zinc ion transport (GO:0006829) | 4.57128861 |
28 | response to endoplasmic reticulum stress (GO:0034976) | 4.54471666 |
29 | homocysteine metabolic process (GO:0050667) | 4.50055939 |
30 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.49086720 |
31 | aspartate family amino acid catabolic process (GO:0009068) | 4.46389028 |
32 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.41772137 |
33 | regulation of nuclease activity (GO:0032069) | 4.38107237 |
34 | cellular response to unfolded protein (GO:0034620) | 4.35014612 |
35 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.33764423 |
36 | maintenance of protein localization in organelle (GO:0072595) | 4.31554160 |
37 | leukotriene biosynthetic process (GO:0019370) | 4.27185631 |
38 | positive regulation of heat generation (GO:0031652) | 4.24962920 |
39 | regulation of metalloenzyme activity (GO:0048552) | 4.20743448 |
40 | regulation of guanylate cyclase activity (GO:0031282) | 4.19274572 |
41 | desmosome organization (GO:0002934) | 4.18426303 |
42 | cellular response to topologically incorrect protein (GO:0035967) | 4.15915964 |
43 | regulation of pseudopodium assembly (GO:0031272) | 4.15610438 |
44 | ER-nucleus signaling pathway (GO:0006984) | 4.14162701 |
45 | intestinal epithelial cell development (GO:0060576) | 4.14020355 |
46 | 4-hydroxyproline metabolic process (GO:0019471) | 4.13712457 |
47 | endocrine pancreas development (GO:0031018) | 4.09733675 |
48 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.08269563 |
49 | negative regulation of epidermis development (GO:0045683) | 4.05186840 |
50 | glutamine metabolic process (GO:0006541) | 4.03659568 |
51 | proline metabolic process (GO:0006560) | 4.01160858 |
52 | L-serine metabolic process (GO:0006563) | 3.96660265 |
53 | signal peptide processing (GO:0006465) | 3.95856274 |
54 | regulation of fever generation (GO:0031620) | 3.93999362 |
55 | steroid catabolic process (GO:0006706) | 3.91700232 |
56 | creatine metabolic process (GO:0006600) | 3.88860386 |
57 | regulation of cholesterol homeostasis (GO:2000188) | 3.87916877 |
58 | positive regulation of actin filament depolymerization (GO:0030836) | 3.73328028 |
59 | serine family amino acid metabolic process (GO:0009069) | 3.72714197 |
60 | L-phenylalanine catabolic process (GO:0006559) | 3.71962451 |
61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.71962451 |
62 | cellular response to zinc ion (GO:0071294) | 3.69513429 |
63 | regulation of keratinocyte differentiation (GO:0045616) | 3.68800833 |
64 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.66970257 |
65 | coenzyme catabolic process (GO:0009109) | 3.66085265 |
66 | neutrophil mediated immunity (GO:0002446) | 3.62249536 |
67 | icosanoid transport (GO:0071715) | 3.59010289 |
68 | fatty acid derivative transport (GO:1901571) | 3.59010289 |
69 | COPII vesicle coating (GO:0048208) | 3.57582596 |
70 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57497757 |
71 | mitochondrion distribution (GO:0048311) | 3.54065518 |
72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.50800445 |
73 | L-phenylalanine metabolic process (GO:0006558) | 3.50800445 |
74 | regulation of keratinocyte proliferation (GO:0010837) | 3.48742643 |
75 | response to unfolded protein (GO:0006986) | 3.47102943 |
76 | sphingolipid catabolic process (GO:0030149) | 3.46176618 |
77 | GDP-mannose metabolic process (GO:0019673) | 3.45441489 |
78 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.44998469 |
79 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.44689142 |
80 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.44022103 |
81 | digestive system process (GO:0022600) | 3.42835768 |
82 | polarized epithelial cell differentiation (GO:0030859) | 3.42449945 |
83 | NADH metabolic process (GO:0006734) | 3.41769490 |
84 | actin filament depolymerization (GO:0030042) | 3.41616051 |
85 | angiotensin maturation (GO:0002003) | 3.36747236 |
86 | response to topologically incorrect protein (GO:0035966) | 3.36072094 |
87 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.32475585 |
88 | glycine transport (GO:0015816) | 3.31264983 |
89 | peptidyl-asparagine modification (GO:0018196) | 3.31007914 |
90 | ER overload response (GO:0006983) | 3.30341886 |
91 | phosphatidylserine metabolic process (GO:0006658) | 3.29967115 |
92 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.23776636 |
93 | antibacterial humoral response (GO:0019731) | 3.23428103 |
94 | cellular protein catabolic process (GO:0044257) | 3.23351562 |
95 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.21681589 |
96 | regulation of heat generation (GO:0031650) | 3.21463368 |
97 | glycine metabolic process (GO:0006544) | 3.20726994 |
98 | cell redox homeostasis (GO:0045454) | 3.17138541 |
99 | cellular glucuronidation (GO:0052695) | 3.16385899 |
100 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 3.14103087 |
101 | sterol transport (GO:0015918) | 3.10732540 |
102 | cholesterol transport (GO:0030301) | 3.10732540 |
103 | cellular response to cadmium ion (GO:0071276) | 3.10258415 |
104 | retinoic acid receptor signaling pathway (GO:0048384) | 3.06810729 |
105 | glucuronate metabolic process (GO:0019585) | 3.03003316 |
106 | uronic acid metabolic process (GO:0006063) | 3.03003316 |
107 | protein N-linked glycosylation (GO:0006487) | 3.02928376 |
108 | doxorubicin metabolic process (GO:0044598) | 3.02709214 |
109 | daunorubicin metabolic process (GO:0044597) | 3.02709214 |
110 | polyketide metabolic process (GO:0030638) | 3.02709214 |
111 | bile acid and bile salt transport (GO:0015721) | 3.02457738 |
112 | sulfur amino acid biosynthetic process (GO:0000097) | 3.02030120 |
113 | pancreas development (GO:0031016) | 3.01421655 |
114 | innate immune response in mucosa (GO:0002227) | 3.01340580 |
115 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.99638998 |
116 | alditol phosphate metabolic process (GO:0052646) | 2.99638579 |
117 | alpha-amino acid biosynthetic process (GO:1901607) | 2.99628800 |
118 | antimicrobial humoral response (GO:0019730) | 2.98794722 |
119 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.97645080 |
120 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.97444744 |
121 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.96404472 |
122 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.92819134 |
123 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.88558041 |
124 | icosanoid secretion (GO:0032309) | 2.88341504 |
125 | arachidonic acid secretion (GO:0050482) | 2.88341504 |
126 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.85371533 |
127 | regulation of cellular extravasation (GO:0002691) | 2.84486337 |
128 | one-carbon metabolic process (GO:0006730) | 2.84386219 |
129 | peptidyl-proline modification (GO:0018208) | 2.83584486 |
130 | negative regulation of cell fate commitment (GO:0010454) | 2.83175384 |
131 | phosphatidic acid biosynthetic process (GO:0006654) | 2.81393205 |
132 | phosphatidic acid metabolic process (GO:0046473) | 2.81393205 |
133 | sulfur amino acid catabolic process (GO:0000098) | 2.81120701 |
134 | glycoside metabolic process (GO:0016137) | 2.80825370 |
135 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.80428928 |
136 | renal system process involved in regulation of blood volume (GO:0001977) | 2.79086791 |
137 | regulation of cellular response to oxidative stress (GO:1900407) | 2.77002248 |
138 | biotin metabolic process (GO:0006768) | 2.74634387 |
139 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.73968015 |
140 | regulation of water loss via skin (GO:0033561) | 2.72586356 |
141 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.72198426 |
142 | epoxygenase P450 pathway (GO:0019373) | 2.71612992 |
143 | * tetrapyrrole metabolic process (GO:0033013) | 2.70894624 |
144 | keratinization (GO:0031424) | 2.69392405 |
145 | hemidesmosome assembly (GO:0031581) | 2.69039954 |
146 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.68832647 |
147 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.68577581 |
148 | hormone catabolic process (GO:0042447) | 2.65584489 |
149 | regulation of epidermal cell differentiation (GO:0045604) | 2.65133685 |
150 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.63720815 |
151 | skin morphogenesis (GO:0043589) | 2.62307121 |
152 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.62099534 |
153 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.61790101 |
154 | establishment of skin barrier (GO:0061436) | 2.60746861 |
155 | phospholipid catabolic process (GO:0009395) | 2.58430987 |
156 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.57567302 |
157 | response to gravity (GO:0009629) | 2.54018731 |
158 | regulation of triglyceride catabolic process (GO:0010896) | 2.51179179 |
159 | bile acid metabolic process (GO:0008206) | 2.48298310 |
160 | L-ascorbic acid metabolic process (GO:0019852) | 2.47414809 |
161 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.47021118 |
162 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.46313816 |
163 | glutathione derivative metabolic process (GO:1901685) | 2.44705704 |
164 | glutathione derivative biosynthetic process (GO:1901687) | 2.44705704 |
165 | intestinal cholesterol absorption (GO:0030299) | 17.8147702 |
166 | exocrine pancreas development (GO:0031017) | 17.2908500 |
167 | * digestion (GO:0007586) | 13.9669543 |
168 | protein retention in ER lumen (GO:0006621) | 12.6723423 |
169 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.8538695 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.88700378 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.42206520 |
3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.26966898 |
4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.91557135 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.88496324 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.65413896 |
7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.94984563 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.85367279 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.68519359 |
10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67694796 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.59484212 |
12 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.51847968 |
13 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.46131552 |
14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.34595105 |
15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28322625 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27546452 |
17 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.27336525 |
18 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.26465302 |
19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.21476301 |
20 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.07623898 |
21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.02511468 |
22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92638999 |
23 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.89951128 |
24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.88154599 |
25 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.88154599 |
26 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.88154599 |
27 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.86463466 |
28 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.86463466 |
29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.81732793 |
30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79596423 |
31 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.78514103 |
32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78460711 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77449753 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75222699 |
35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75214844 |
36 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73194608 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72472316 |
38 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71407538 |
39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70660173 |
40 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.68790044 |
41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63399194 |
42 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.62309418 |
43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60606886 |
44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60032210 |
45 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57662150 |
46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.56528281 |
47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53345632 |
48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51052692 |
49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50191361 |
50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48263100 |
51 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.45157045 |
52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.44887993 |
53 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43537325 |
54 | P68_20966046_ChIP-Seq_HELA_Human | 1.43456949 |
55 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39904504 |
56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34589597 |
57 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.34446501 |
58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33909243 |
59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32692388 |
60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31675897 |
61 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.31311092 |
62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29791406 |
63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27707473 |
64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26426010 |
65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.24691516 |
66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24129754 |
67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23181209 |
68 | ERA_21632823_ChIP-Seq_H3396_Human | 1.22681850 |
69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22551388 |
70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21838102 |
71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21448190 |
72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.19037483 |
73 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16286078 |
74 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.16164793 |
75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15982118 |
76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15829341 |
77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.14958804 |
78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14047278 |
79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11507661 |
80 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.11368405 |
81 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.10826558 |
82 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.10387862 |
83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10289574 |
84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09840211 |
85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09309656 |
86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08990384 |
87 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08231612 |
88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06211206 |
89 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05870729 |
90 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.05677565 |
91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05137990 |
92 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04881685 |
93 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04688524 |
94 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03844138 |
95 | CBP_21632823_ChIP-Seq_H3396_Human | 1.03125964 |
96 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03086650 |
97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02901776 |
98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01779530 |
99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01515309 |
100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01350090 |
101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00953538 |
102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00157631 |
103 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98842208 |
104 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.98700469 |
105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.98668887 |
106 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.98235901 |
107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98063184 |
108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98037538 |
109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97980321 |
110 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.97403198 |
111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97287825 |
112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94742472 |
113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93937737 |
114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.93461453 |
115 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93359855 |
116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93304802 |
117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91159135 |
118 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.91121063 |
119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90918917 |
120 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90036451 |
121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89963179 |
122 | P300_27268052_Chip-Seq_Bcells_Human | 0.89562143 |
123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89542065 |
124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89382978 |
125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88943904 |
126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87919257 |
127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87689032 |
128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87368199 |
129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87191622 |
130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87062401 |
131 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85930546 |
132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85907297 |
133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85751950 |
134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85482146 |
135 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85181844 |
136 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84948865 |
137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84586607 |
138 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84402046 |
139 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.84340344 |
140 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83901251 |
141 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83766554 |
142 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83766554 |
143 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82622894 |
144 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82329327 |
145 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.82231344 |
146 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78928848 |
147 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77951878 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005083_abnormal_biliary_tract | 9.47092985 |
2 | MP0001666_abnormal_nutrient_absorption | 9.05814174 |
3 | MP0005220_abnormal_exocrine_pancreas | 6.75605269 |
4 | MP0005365_abnormal_bile_salt | 6.53313720 |
5 | MP0003868_abnormal_feces_composition | 5.23358395 |
6 | MP0005084_abnormal_gallbladder_morpholo | 5.13299486 |
7 | MP0005085_abnormal_gallbladder_physiolo | 3.40099848 |
8 | MP0002693_abnormal_pancreas_physiology | 2.82752106 |
9 | MP0009840_abnormal_foam_cell | 2.78248687 |
10 | MP0003959_abnormal_lean_body | 2.53180985 |
11 | MP0001664_abnormal_digestion | 2.48912617 |
12 | MP0002139_abnormal_hepatobiliary_system | 2.28034896 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.13059515 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.07885165 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.03740794 |
16 | MP0001944_abnormal_pancreas_morphology | 1.99659518 |
17 | MP0002138_abnormal_hepatobiliary_system | 1.92800553 |
18 | MP0004264_abnormal_extraembryonic_tissu | 1.79289924 |
19 | MP0010352_gastrointestinal_tract_polyps | 1.72613641 |
20 | MP0005448_abnormal_energy_balance | 1.61378988 |
21 | MP0004233_abnormal_muscle_weight | 1.60623237 |
22 | MP0005501_abnormal_skin_physiology | 1.59269537 |
23 | MP0010234_abnormal_vibrissa_follicle | 1.51174962 |
24 | MP0010386_abnormal_urinary_bladder | 1.43096966 |
25 | MP0003638_abnormal_response/metabolism_ | 1.42584817 |
26 | MP0004147_increased_porphyrin_level | 1.41318829 |
27 | MP0003252_abnormal_bile_duct | 1.38266354 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.37150918 |
29 | MP0005166_decreased_susceptibility_to | 1.36460150 |
30 | MP0003950_abnormal_plasma_membrane | 1.34950365 |
31 | MP0002928_abnormal_bile_duct | 1.27245278 |
32 | MP0005451_abnormal_body_composition | 1.23796091 |
33 | MP0005332_abnormal_amino_acid | 1.22494286 |
34 | MP0003566_abnormal_cell_adhesion | 1.20613994 |
35 | MP0001765_abnormal_ion_homeostasis | 1.16874787 |
36 | MP0002277_abnormal_respiratory_mucosa | 1.16016991 |
37 | MP0001216_abnormal_epidermal_layer | 1.14013663 |
38 | MP0005257_abnormal_intraocular_pressure | 1.12461766 |
39 | MP0005165_increased_susceptibility_to | 1.12020769 |
40 | MP0003075_altered_response_to | 1.12013611 |
41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11541361 |
42 | MP0001756_abnormal_urination | 1.09275487 |
43 | MP0003183_abnormal_peptide_metabolism | 1.09116626 |
44 | MP0002078_abnormal_glucose_homeostasis | 1.04484870 |
45 | MP0005670_abnormal_white_adipose | 1.03774650 |
46 | MP0010155_abnormal_intestine_physiology | 1.03631143 |
47 | MP0005636_abnormal_mineral_homeostasis | 1.02884344 |
48 | MP0003283_abnormal_digestive_organ | 1.02788900 |
49 | MP0003879_abnormal_hair_cell | 0.99003829 |
50 | MP0009379_abnormal_foot_pigmentation | 0.98972755 |
51 | MP0000470_abnormal_stomach_morphology | 0.96595514 |
52 | MP0000003_abnormal_adipose_tissue | 0.95919358 |
53 | MP0000013_abnormal_adipose_tissue | 0.95614196 |
54 | MP0003453_abnormal_keratinocyte_physiol | 0.95429538 |
55 | MP0003866_abnormal_defecation | 0.92180528 |
56 | MP0008789_abnormal_olfactory_epithelium | 0.92097544 |
57 | MP0008004_abnormal_stomach_pH | 0.91609332 |
58 | MP0008438_abnormal_cutaneous_collagen | 0.89788171 |
59 | MP0005408_hypopigmentation | 0.89622613 |
60 | MP0010771_integument_phenotype | 0.85703566 |
61 | MP0000762_abnormal_tongue_morphology | 0.85331209 |
62 | MP0005409_darkened_coat_color | 0.84619401 |
63 | MP0000462_abnormal_digestive_system | 0.84059397 |
64 | MP0003315_abnormal_perineum_morphology | 0.81971724 |
65 | MP0001501_abnormal_sleep_pattern | 0.79283145 |
66 | MP0000477_abnormal_intestine_morphology | 0.78992195 |
67 | MP0005535_abnormal_body_temperature | 0.78787529 |
68 | MP0000467_abnormal_esophagus_morphology | 0.78661599 |
69 | MP0009643_abnormal_urine_homeostasis | 0.78490323 |
70 | MP0000538_abnormal_urinary_bladder | 0.78219687 |
71 | MP0005367_renal/urinary_system_phenotyp | 0.78178326 |
72 | MP0000516_abnormal_urinary_system | 0.78178326 |
73 | MP0005023_abnormal_wound_healing | 0.77642876 |
74 | MP0002136_abnormal_kidney_physiology | 0.74755214 |
75 | MP0000537_abnormal_urethra_morphology | 0.74339627 |
76 | MP0009384_cardiac_valve_regurgitation | 0.73978224 |
77 | MP0003953_abnormal_hormone_level | 0.73859134 |
78 | MP0005499_abnormal_olfactory_system | 0.72210222 |
79 | MP0005394_taste/olfaction_phenotype | 0.72210222 |
80 | MP0000613_abnormal_salivary_gland | 0.72132754 |
81 | MP0000490_abnormal_crypts_of | 0.71335854 |
82 | MP0006054_spinal_hemorrhage | 0.68005077 |
83 | MP0005058_abnormal_lysosome_morphology | 0.67627916 |
84 | MP0001873_stomach_inflammation | 0.67330311 |
85 | MP0010329_abnormal_lipoprotein_level | 0.67230093 |
86 | MP0000858_altered_metastatic_potential | 0.65313489 |
87 | MP0008961_abnormal_basal_metabolism | 0.63156349 |
88 | MP0002006_tumorigenesis | 0.63113777 |
89 | MP0005452_abnormal_adipose_tissue | 0.63087058 |
90 | MP0005360_urolithiasis | 0.62848306 |
91 | MP0003806_abnormal_nucleotide_metabolis | 0.62748120 |
92 | MP0000678_abnormal_parathyroid_gland | 0.60437005 |
93 | MP0004510_myositis | 0.58935416 |
94 | MP0010368_abnormal_lymphatic_system | 0.58567907 |
95 | MP0003045_fibrosis | 0.57869594 |
96 | MP0004782_abnormal_surfactant_physiolog | 0.57360785 |
97 | MP0000598_abnormal_liver_morphology | 0.56253178 |
98 | MP0000230_abnormal_systemic_arterial | 0.55508470 |
99 | MP0006036_abnormal_mitochondrial_physio | 0.54986528 |
100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54879905 |
101 | MP0009780_abnormal_chondrocyte_physiolo | 0.51013288 |
102 | MP0005375_adipose_tissue_phenotype | 0.50574615 |
103 | MP0001663_abnormal_digestive_system | 0.49780496 |
104 | MP0000609_abnormal_liver_physiology | 0.49297427 |
105 | MP0001731_abnormal_postnatal_growth | 0.48785323 |
106 | MP0002089_abnormal_postnatal_growth/wei | 0.48160928 |
107 | MP0009765_abnormal_xenobiotic_induced | 0.47685140 |
108 | MP0004185_abnormal_adipocyte_glucose | 0.45223970 |
109 | MP0002098_abnormal_vibrissa_morphology | 0.43944284 |
110 | MP0003122_maternal_imprinting | 0.43281191 |
111 | MP0002796_impaired_skin_barrier | 0.42908780 |
112 | MP0003186_abnormal_redox_activity | 0.42632374 |
113 | MP0005381_digestive/alimentary_phenotyp | 0.42537002 |
114 | MP0001764_abnormal_homeostasis | 0.41281704 |
115 | MP0000750_abnormal_muscle_regeneration | 0.39687763 |
116 | MP0001845_abnormal_inflammatory_respons | 0.38545721 |
117 | MP0002060_abnormal_skin_morphology | 0.36917857 |
118 | MP0005319_abnormal_enzyme/_coenzyme | 0.36317589 |
119 | MP0005334_abnormal_fat_pad | 0.34666967 |
120 | MP0000955_abnormal_spinal_cord | 0.34526114 |
121 | MP0003329_amyloid_beta_deposits | 0.34424412 |
122 | MP0002069_abnormal_eating/drinking_beha | 0.34350967 |
123 | MP0003300_gastrointestinal_ulcer | 0.33662125 |
124 | MP0000377_abnormal_hair_follicle | 0.33606515 |
125 | MP0009703_decreased_birth_body | 0.32030600 |
126 | MP0000367_abnormal_coat/_hair | 0.31701948 |
127 | MP0009642_abnormal_blood_homeostasis | 0.30447044 |
128 | MP0010678_abnormal_skin_adnexa | 0.30004150 |
129 | MP0005187_abnormal_penis_morphology | 0.29440606 |
130 | MP0003123_paternal_imprinting | 0.29233358 |
131 | MP0003795_abnormal_bone_structure | 0.28968578 |
132 | MP0003172_abnormal_lysosome_physiology | 0.27292483 |
133 | MP0000371_diluted_coat_color | 0.27291680 |
134 | MP0004924_abnormal_behavior | 0.24672654 |
135 | MP0005386_behavior/neurological_phenoty | 0.24672654 |
136 | MP0002896_abnormal_bone_mineralization | 0.24168661 |
137 | MP0004043_abnormal_pH_regulation | 0.24132753 |
138 | MP0003943_abnormal_hepatobiliary_system | 0.24015659 |
139 | MP0003956_abnormal_body_size | 0.23830209 |
140 | MP0000647_abnormal_sebaceous_gland | 0.23740822 |
141 | MP0008872_abnormal_physiological_respon | 0.22237550 |
142 | MP0009333_abnormal_splenocyte_physiolog | 0.22178659 |
143 | MP0004272_abnormal_basement_membrane | 0.22095819 |
144 | MP0001348_abnormal_lacrimal_gland | 0.21605562 |
145 | MP0009672_abnormal_birth_weight | 0.20947719 |
146 | MP0002876_abnormal_thyroid_physiology | 0.20835105 |
147 | MP0000778_abnormal_nervous_system | 0.19669819 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fat malabsorption (HP:0002630) | 8.67221197 |
2 | Exocrine pancreatic insufficiency (HP:0001738) | 7.80524086 |
3 | Hypoproteinemia (HP:0003075) | 7.14417375 |
4 | Gout (HP:0001997) | 6.04450155 |
5 | Short chin (HP:0000331) | 5.99403656 |
6 | Decreased subcutaneous fat (HP:0001002) | 5.52656523 |
7 | Type I diabetes mellitus (HP:0100651) | 5.17272370 |
8 | Abnormality of subcutaneous fat tissue (HP:0001001) | 4.96316327 |
9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.82779787 |
10 | Maternal diabetes (HP:0009800) | 4.70525968 |
11 | Pancreatitis (HP:0001733) | 4.61537181 |
12 | Abnormal pancreas size (HP:0012094) | 4.43744858 |
13 | Abnormality of the intrinsic pathway (HP:0010989) | 4.29778829 |
14 | Vascular calcification (HP:0004934) | 4.11639349 |
15 | Hypoplasia of the pons (HP:0012110) | 4.00793595 |
16 | Ketoacidosis (HP:0001993) | 3.83377104 |
17 | Ketosis (HP:0001946) | 3.82577459 |
18 | Abnormality of the pons (HP:0007361) | 3.71859984 |
19 | Premature skin wrinkling (HP:0100678) | 3.67599140 |
20 | Joint stiffness (HP:0001387) | 3.67486354 |
21 | Abnormality of proline metabolism (HP:0010907) | 3.65669908 |
22 | Hydroxyprolinuria (HP:0003080) | 3.65669908 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.64453732 |
24 | Cardiovascular calcification (HP:0011915) | 3.64318245 |
25 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.59859221 |
26 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.59859221 |
27 | Ileus (HP:0002595) | 3.45064862 |
28 | Malnutrition (HP:0004395) | 3.24817171 |
29 | Cortical dysplasia (HP:0002539) | 3.20650712 |
30 | Tubulointerstitial fibrosis (HP:0005576) | 3.08249580 |
31 | Hypoglycemic coma (HP:0001325) | 3.00484891 |
32 | Tubulointerstitial nephritis (HP:0001970) | 2.97901432 |
33 | Late onset (HP:0003584) | 2.95059234 |
34 | Axonal loss (HP:0003447) | 2.92865418 |
35 | Hyperactive renin-angiotensin system (HP:0000841) | 2.91956393 |
36 | Alopecia of scalp (HP:0002293) | 2.86246133 |
37 | Carpal bone hypoplasia (HP:0001498) | 2.78114425 |
38 | Hyperglycinemia (HP:0002154) | 2.75767567 |
39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.74946027 |
40 | Optic nerve hypoplasia (HP:0000609) | 2.71276261 |
41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70912952 |
42 | Long foot (HP:0001833) | 2.68143928 |
43 | Delayed CNS myelination (HP:0002188) | 2.67749864 |
44 | Xanthomatosis (HP:0000991) | 2.66882704 |
45 | Hypoglycemic seizures (HP:0002173) | 2.65415176 |
46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.64633752 |
47 | Congenital glaucoma (HP:0001087) | 2.61479722 |
48 | Increased purine levels (HP:0004368) | 2.61040606 |
49 | Hyperuricemia (HP:0002149) | 2.61040606 |
50 | Plantar hyperkeratosis (HP:0007556) | 2.59328694 |
51 | Palmoplantar hyperkeratosis (HP:0000972) | 2.59082524 |
52 | Abnormality of vitamin B metabolism (HP:0004340) | 2.58844306 |
53 | Glycosuria (HP:0003076) | 2.58628435 |
54 | Abnormality of urine glucose concentration (HP:0011016) | 2.58628435 |
55 | Prenatal maternal abnormality (HP:0002686) | 2.57878153 |
56 | Amyloidosis (HP:0011034) | 2.56862017 |
57 | Abnormal hair laboratory examination (HP:0003328) | 2.52017266 |
58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.50789697 |
59 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.49106304 |
60 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.45319001 |
61 | Growth hormone excess (HP:0000845) | 2.42067337 |
62 | Insulin resistance (HP:0000855) | 2.40768721 |
63 | Abnormality of vitamin metabolism (HP:0100508) | 2.39683687 |
64 | Villous atrophy (HP:0011473) | 2.37391786 |
65 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.37391786 |
66 | Tetraparesis (HP:0002273) | 2.36102809 |
67 | Abnormality of glycine metabolism (HP:0010895) | 2.33773896 |
68 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.33773896 |
69 | Palmar hyperkeratosis (HP:0010765) | 2.31984162 |
70 | Onycholysis (HP:0001806) | 2.30989084 |
71 | Abnormal tarsal ossification (HP:0008369) | 2.30779534 |
72 | Hyperglycinuria (HP:0003108) | 2.29825600 |
73 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.29279473 |
74 | Fatigue (HP:0012378) | 2.29257506 |
75 | Glucose intolerance (HP:0000833) | 2.29162180 |
76 | Pili torti (HP:0003777) | 2.26944875 |
77 | Abnormal protein glycosylation (HP:0012346) | 2.26004285 |
78 | Abnormal glycosylation (HP:0012345) | 2.26004285 |
79 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.26004285 |
80 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.26004285 |
81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.25874526 |
82 | Pectus carinatum (HP:0000768) | 2.25051324 |
83 | Abnormality of the pleura (HP:0002103) | 2.23236192 |
84 | Abnormal glucose tolerance (HP:0001952) | 2.16406181 |
85 | Progressive muscle weakness (HP:0003323) | 2.13085706 |
86 | Large for gestational age (HP:0001520) | 2.13008634 |
87 | Intrahepatic cholestasis (HP:0001406) | 2.12996028 |
88 | Short nail (HP:0001799) | 2.12669151 |
89 | Hypoplasia of the odontoid process (HP:0003311) | 2.12552708 |
90 | Decreased circulating renin level (HP:0003351) | 2.12108738 |
91 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11983702 |
92 | Hyperglycemia (HP:0003074) | 2.11417693 |
93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09930490 |
94 | Osteolytic defects of the hand bones (HP:0009699) | 2.09930490 |
95 | Esophageal varix (HP:0002040) | 2.09648970 |
96 | Dysostosis multiplex (HP:0000943) | 2.09262978 |
97 | Proximal tubulopathy (HP:0000114) | 2.08578073 |
98 | Distal upper limb amyotrophy (HP:0007149) | 2.08008785 |
99 | Upper limb amyotrophy (HP:0009129) | 2.08008785 |
100 | Acanthosis nigricans (HP:0000956) | 2.05017874 |
101 | Abdominal distention (HP:0003270) | 2.03870141 |
102 | Type II lissencephaly (HP:0007260) | 2.02554088 |
103 | Ventricular fibrillation (HP:0001663) | 2.01794896 |
104 | Confusion (HP:0001289) | 2.00996789 |
105 | Steatorrhea (HP:0002570) | 10.7125674 |
106 | Hypobetalipoproteinemia (HP:0003563) | 1.99188996 |
107 | Abnormality of renin-angiotensin system (HP:0000847) | 1.98239500 |
108 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.97666550 |
109 | Vacuolated lymphocytes (HP:0001922) | 1.97600926 |
110 | Small epiphyses (HP:0010585) | 1.96496357 |
111 | Hand muscle atrophy (HP:0009130) | 1.95515803 |
112 | Abnormality of methionine metabolism (HP:0010901) | 1.94386322 |
113 | Enlarged penis (HP:0000040) | 1.93674412 |
114 | Alkalosis (HP:0001948) | 1.93584472 |
115 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92770415 |
116 | Sparse eyelashes (HP:0000653) | 1.91244585 |
117 | Acute hepatic failure (HP:0006554) | 1.91016002 |
118 | Hyperammonemia (HP:0001987) | 1.90851650 |
119 | Dehydration (HP:0001944) | 1.90697394 |
120 | Opisthotonus (HP:0002179) | 1.90499216 |
121 | Cortical visual impairment (HP:0100704) | 1.89836400 |
122 | Woolly hair (HP:0002224) | 1.89106196 |
123 | Hypsarrhythmia (HP:0002521) | 1.88969536 |
124 | Popliteal pterygium (HP:0009756) | 1.88539591 |
125 | Palpitations (HP:0001962) | 1.88412168 |
126 | Methylmalonic aciduria (HP:0012120) | 1.86982197 |
127 | Abnormality of nail color (HP:0100643) | 1.86882360 |
128 | Hypoplasia of the uterus (HP:0000013) | 1.86608787 |
129 | Distal lower limb muscle weakness (HP:0009053) | 1.86509465 |
130 | Homocystinuria (HP:0002156) | 1.86391422 |
131 | Abnormality of homocysteine metabolism (HP:0010919) | 1.86391422 |
132 | Abnormality of the Achilles tendon (HP:0005109) | 1.85223654 |
133 | Right ventricular cardiomyopathy (HP:0011663) | 1.85097427 |
134 | Myocardial infarction (HP:0001658) | 1.85087872 |
135 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85000586 |
136 | Focal segmental glomerulosclerosis (HP:0000097) | 1.84936857 |
137 | Ankyloglossia (HP:0010296) | 1.84764000 |
138 | Type I transferrin isoform profile (HP:0003642) | 1.84303682 |
139 | Adrenal hypoplasia (HP:0000835) | 1.84301997 |
140 | Infantile muscular hypotonia (HP:0008947) | 1.82617287 |
141 | Metabolic alkalosis (HP:0200114) | 1.82087911 |
142 | Fragile nails (HP:0001808) | 1.79919066 |
143 | Milia (HP:0001056) | 1.78902980 |
144 | Hyperphosphaturia (HP:0003109) | 1.78370557 |
145 | Hepatocellular necrosis (HP:0001404) | 1.78342827 |
146 | EEG with generalized epileptiform discharges (HP:0011198) | 1.77932084 |
147 | Hepatic necrosis (HP:0002605) | 1.77431869 |
148 | Prolonged neonatal jaundice (HP:0006579) | 1.77199075 |
149 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.77129376 |
150 | Oral leukoplakia (HP:0002745) | 1.75696409 |
151 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.75232766 |
152 | Tubular atrophy (HP:0000092) | 1.74692665 |
153 | Hypokinesia (HP:0002375) | 1.74626914 |
154 | Hypolipoproteinemia (HP:0010981) | 1.74453080 |
155 | Hyperparathyroidism (HP:0000843) | 1.74284819 |
156 | Congenital, generalized hypertrichosis (HP:0004540) | 1.73750676 |
157 | Multiple lipomas (HP:0001012) | 1.73750001 |
158 | Spastic diplegia (HP:0001264) | 1.73238188 |
159 | Tubulointerstitial abnormality (HP:0001969) | 1.72970255 |
160 | Distal lower limb amyotrophy (HP:0008944) | 1.72949442 |
161 | Large hands (HP:0001176) | 1.72476714 |
162 | Atrophic scars (HP:0001075) | 1.72020038 |
163 | Hyperphosphatemia (HP:0002905) | 1.71632626 |
164 | Congenital sensorineural hearing impairment (HP:0008527) | 1.71593015 |
165 | Deep venous thrombosis (HP:0002625) | 1.70601582 |
166 | Tongue fasciculations (HP:0001308) | 1.70538200 |
167 | Hypotension (HP:0002615) | 1.69706796 |
168 | Renal tubular acidosis (HP:0001947) | 1.69199091 |
169 | Vertebral compression fractures (HP:0002953) | 1.69184419 |
170 | Epileptiform EEG discharges (HP:0011182) | 1.69016608 |
171 | Abnormality of the odontoid process (HP:0003310) | 1.68863180 |
172 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.68404885 |
173 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.68091937 |
174 | Reduced antithrombin III activity (HP:0001976) | 1.67765356 |
175 | Abnormality of purine metabolism (HP:0004352) | 1.65732451 |
176 | Barrel-shaped chest (HP:0001552) | 1.65342192 |
177 | Anal atresia (HP:0002023) | 1.62309918 |
178 | Abnormality of the renal cortex (HP:0011035) | 1.62181367 |
179 | Athetosis (HP:0002305) | 1.61887907 |
180 | Abnormal foot bone ossification (HP:0010675) | 1.61732820 |
181 | Symptomatic seizures (HP:0011145) | 1.61073344 |
182 | Prolonged QT interval (HP:0001657) | 1.60238216 |
183 | Absent eyelashes (HP:0000561) | 1.57374478 |
184 | Conjugated hyperbilirubinemia (HP:0002908) | 1.57317581 |
185 | Severe short stature (HP:0003510) | 1.57163698 |
186 | Redundant skin (HP:0001582) | 1.56114233 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 9.68168469 |
2 | EPHA2 | 7.56567704 |
3 | MST1R | 6.24133069 |
4 | LMTK2 | 5.49481741 |
5 | ERN1 | 5.42472810 |
6 | MAP2K2 | 4.27018944 |
7 | TRIB3 | 4.16095695 |
8 | EIF2AK3 | 4.04931174 |
9 | PKN2 | 3.70938462 |
10 | TESK1 | 3.41952734 |
11 | INSRR | 2.86367512 |
12 | MAP3K12 | 2.70532537 |
13 | MST4 | 2.48395302 |
14 | TESK2 | 2.41004979 |
15 | LIMK1 | 2.35964661 |
16 | EPHB2 | 2.18137093 |
17 | FRK | 1.90967474 |
18 | MAPKAPK3 | 1.83152850 |
19 | MAPK15 | 1.77042289 |
20 | MAP3K3 | 1.75232763 |
21 | MAP2K1 | 1.75009145 |
22 | PAK2 | 1.66150592 |
23 | ZAP70 | 1.64798113 |
24 | ARAF | 1.57093466 |
25 | NME1 | 1.54667512 |
26 | PRKG2 | 1.52168805 |
27 | PAK4 | 1.50119954 |
28 | PHKG2 | 1.49629864 |
29 | PHKG1 | 1.49629864 |
30 | PIM2 | 1.49545104 |
31 | WNK4 | 1.44132019 |
32 | SCYL2 | 1.43531508 |
33 | ACVR1B | 1.39301894 |
34 | NME2 | 1.38844850 |
35 | PTK6 | 1.35651268 |
36 | TAOK3 | 1.35155289 |
37 | MYLK | 1.29045849 |
38 | DYRK1A | 1.26315669 |
39 | VRK2 | 1.26082108 |
40 | IRAK3 | 1.25844370 |
41 | RPS6KB2 | 1.25666041 |
42 | DAPK1 | 1.18424659 |
43 | EEF2K | 1.15998227 |
44 | CAMKK1 | 1.10303111 |
45 | FLT3 | 1.08009753 |
46 | PDGFRB | 0.97647837 |
47 | ABL2 | 0.97335637 |
48 | SIK1 | 0.92073090 |
49 | DAPK2 | 0.90944135 |
50 | STK24 | 0.87533598 |
51 | BMX | 0.86939370 |
52 | EPHA4 | 0.86508205 |
53 | ERBB4 | 0.83630367 |
54 | PTK2B | 0.80468769 |
55 | PIK3CG | 0.79115581 |
56 | MAP3K2 | 0.77967297 |
57 | RET | 0.77313001 |
58 | MTOR | 0.77129348 |
59 | TIE1 | 0.74282700 |
60 | PIK3CA | 0.69598416 |
61 | RIPK1 | 0.67855563 |
62 | PASK | 0.67328692 |
63 | MAP2K7 | 0.66275060 |
64 | LATS1 | 0.65150434 |
65 | MAP2K6 | 0.63772519 |
66 | GRK1 | 0.63589296 |
67 | LRRK2 | 0.62964908 |
68 | KSR2 | 0.62734921 |
69 | OXSR1 | 0.62402506 |
70 | PRKD3 | 0.61828096 |
71 | DYRK1B | 0.61278397 |
72 | HIPK2 | 0.59211883 |
73 | STK10 | 0.59191157 |
74 | ILK | 0.58622040 |
75 | MAP3K11 | 0.58391034 |
76 | PRKCZ | 0.58117680 |
77 | PRKCI | 0.57983731 |
78 | FGFR4 | 0.57555168 |
79 | PRKCH | 0.56852043 |
80 | STK39 | 0.56333412 |
81 | CAMKK2 | 0.54818498 |
82 | TAOK2 | 0.53903784 |
83 | STK38 | 0.52920062 |
84 | PDPK1 | 0.51312421 |
85 | PDGFRA | 0.49087520 |
86 | CDK8 | 0.46780897 |
87 | NTRK1 | 0.45800663 |
88 | STK16 | 0.45037412 |
89 | MAP3K9 | 0.44102242 |
90 | RPS6KB1 | 0.43834279 |
91 | DAPK3 | 0.42202095 |
92 | FER | 0.42133632 |
93 | TGFBR2 | 0.41279161 |
94 | PRPF4B | 0.41233306 |
95 | MAPK12 | 0.40434840 |
96 | PDK1 | 0.40189055 |
97 | EPHB1 | 0.40082748 |
98 | PTK2 | 0.39403380 |
99 | ROCK1 | 0.38933165 |
100 | PDK2 | 0.36654205 |
101 | MAPK3 | 0.35902498 |
102 | MAP3K1 | 0.35723266 |
103 | PRKCE | 0.35216844 |
104 | PRKACB | 0.34846317 |
105 | CAMK2G | 0.34405723 |
106 | MAP3K7 | 0.34333147 |
107 | CAMK2D | 0.33856714 |
108 | NTRK3 | 0.33633461 |
109 | DDR2 | 0.33386346 |
110 | TYRO3 | 0.32489932 |
111 | TRPM7 | 0.32402724 |
112 | NEK1 | 0.30614400 |
113 | ROCK2 | 0.30608281 |
114 | ADRBK1 | 0.30590435 |
115 | IRAK2 | 0.29918157 |
116 | STK38L | 0.29783117 |
117 | MAP4K2 | 0.28056299 |
118 | PINK1 | 0.28050914 |
119 | MOS | 0.28020166 |
120 | RPS6KA1 | 0.27324429 |
121 | JAK2 | 0.27067631 |
122 | CAMK1D | 0.26124057 |
123 | BRAF | 0.25328577 |
124 | TAOK1 | 0.24818402 |
125 | EIF2AK1 | 0.24805575 |
126 | MET | 0.23292920 |
127 | PRKD1 | 0.22649984 |
128 | PAK1 | 0.21831499 |
129 | MAPK1 | 0.20927222 |
130 | ERBB3 | 0.18999332 |
131 | ABL1 | 0.18919939 |
132 | MATK | 0.17169002 |
133 | SRC | 0.16796677 |
134 | TBK1 | 0.16660164 |
135 | CSNK1E | 0.16122585 |
136 | DYRK2 | 0.15978286 |
137 | PRKCA | 0.15927194 |
138 | MAPK11 | 0.14940190 |
139 | KDR | 0.14645853 |
140 | GSK3A | 0.14488146 |
141 | IGF1R | 0.14392483 |
142 | AKT1 | 0.14337900 |
143 | NEK6 | 0.14325422 |
144 | ICK | 0.13516039 |
145 | IRAK4 | 0.13176880 |
146 | MAP2K4 | 0.12643548 |
147 | CDK5 | 0.10728647 |
148 | RPS6KA3 | 0.10550479 |
149 | PAK6 | 0.10412204 |
150 | CSNK1A1 | 0.10304867 |
151 | EPHA3 | 0.10087673 |
152 | CDK19 | 0.10059497 |
153 | CSNK1G3 | 0.10044742 |
154 | MAP3K8 | 0.09465716 |
155 | MAP3K10 | 0.08855163 |
156 | ERBB2 | 0.08327205 |
157 | GRK5 | 0.07991873 |
158 | CDK4 | 0.07958386 |
159 | PRKACA | 0.07418689 |
160 | CAMK1G | 0.07188412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Pancreatic secretion_Homo sapiens_hsa04972 | 8.48802811 |
2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.05781953 |
3 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 5.63993166 |
4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.70955494 |
5 | Protein export_Homo sapiens_hsa03060 | 3.31481613 |
6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.98242635 |
7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.78670894 |
8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.77164451 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55592704 |
10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.21514509 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05144793 |
12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.82798404 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71900803 |
14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.71346639 |
15 | Mineral absorption_Homo sapiens_hsa04978 | 1.70399142 |
16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56389804 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51834747 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40876139 |
19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.37845249 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33351412 |
21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.26618767 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19438286 |
23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16960373 |
24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15554620 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14466558 |
26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12972376 |
27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10610711 |
28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08901003 |
29 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05831494 |
30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05281926 |
31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99577093 |
32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.97659142 |
33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91628997 |
34 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91449197 |
35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91169861 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89019402 |
37 | Proteasome_Homo sapiens_hsa03050 | 0.87038395 |
38 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86697774 |
39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86566021 |
40 | Insulin secretion_Homo sapiens_hsa04911 | 0.84308887 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83185583 |
42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82799643 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81765273 |
44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80678250 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78606224 |
46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76485247 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73403935 |
48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71421074 |
49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69782069 |
50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68145245 |
51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.66565911 |
52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66450221 |
53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66266326 |
54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65719433 |
55 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62946380 |
56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61260425 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59485727 |
58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58461335 |
59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58329661 |
60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57887388 |
61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57659472 |
62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57644377 |
63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57161306 |
64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56727939 |
65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54341784 |
66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53977306 |
67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52702492 |
68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50855911 |
69 | * Influenza A_Homo sapiens_hsa05164 | 0.50191683 |
70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47868098 |
71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46833868 |
72 | Salivary secretion_Homo sapiens_hsa04970 | 0.45462279 |
73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45419321 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43209898 |
75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42576658 |
76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42238709 |
77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42049678 |
78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41533767 |
79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39638400 |
80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38818154 |
81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36496726 |
82 | Tight junction_Homo sapiens_hsa04530 | 0.35180490 |
83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34658337 |
84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32780987 |
85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32457376 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30832240 |
87 | Legionellosis_Homo sapiens_hsa05134 | 0.30312638 |
88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29489441 |
89 | Lysosome_Homo sapiens_hsa04142 | 0.28504914 |
90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27709085 |
91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27482521 |
92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25562647 |
93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25211689 |
94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23671952 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22093255 |
96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21398836 |
97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.21186323 |
98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21122953 |
99 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19332579 |
100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.18866186 |
101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18289989 |
102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.17356433 |
103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15543660 |
104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.15372981 |
105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14964049 |
106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14958281 |
107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14956199 |
108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14756501 |
109 | Prostate cancer_Homo sapiens_hsa05215 | 0.12974181 |
110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12706704 |
111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.12226711 |
112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.09283128 |
113 | Hepatitis C_Homo sapiens_hsa05160 | 0.08716595 |
114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.08656692 |
115 | Bile secretion_Homo sapiens_hsa04976 | 0.07664780 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.07570520 |
117 | Bladder cancer_Homo sapiens_hsa05219 | 0.07565295 |
118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.06609802 |
119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.06044302 |
120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05991647 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05480823 |
122 | Endocytosis_Homo sapiens_hsa04144 | 0.05398802 |
123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04961917 |
124 | Histidine metabolism_Homo sapiens_hsa00340 | 0.04710453 |
125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.03937481 |
126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03278749 |
127 | Lysine degradation_Homo sapiens_hsa00310 | 0.03086564 |
128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.02456403 |
129 | Peroxisome_Homo sapiens_hsa04146 | 0.02404748 |
130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.02404683 |
131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01992147 |
132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.01578004 |
133 | Viral myocarditis_Homo sapiens_hsa05416 | 0.01391983 |
134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.00907674 |
135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00866565 |
136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00196586 |
137 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0184578 |
138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0142427 |
139 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0059150 |